KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 150 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,990,000 | -86.9% | 500,000 | -83.3% | 0.34% | -87.5% |
| Q1 2015 | $38,190,000 | -10.0% | 3,000,000 | 0.0% | 2.73% | -3.4% |
| Q4 2014 | $42,450,000 | -11.8% | 3,000,000 | -14.3% | 2.82% | -37.6% |
| Q3 2014 | $48,125,000 | +4.3% | 3,500,000 | +16.7% | 4.52% | +49.6% |
| Q2 2014 | $46,140,000 | +116.6% | 3,000,000 | +140.0% | 3.02% | +81.1% |
| Q1 2014 | $21,300,000 | – | 1,250,000 | – | 1.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |